Oscar Health

OSCR

Market cap $8.9B

OSCR Hedge Fund Activity: Q1 2026 in Review

330 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Oscar Health (OSCR) for Q1 2026, worth a combined $2.01B — down 17% from $2.42B a quarter earlier.

Sellers outnumbered buyers: 67 funds closed out of OSCR and 63 opened new positions — a net loss of 4 holders — while 101 trimmed existing stakes and 118 added.

The largest buyer was T. Rowe Price Investment Management, adding an estimated $34.2M. The largest seller was Morgan Stanley, cutting an estimated $48.7M.

• 330 institutional investors held Oscar Health (OSCR) as of Q1 2026, down from 341 in Q4 2025.
• Funds reported $2.01B of Oscar Health stock for Q1 2026, down 17% quarter-over-quarter.
• 63 funds opened new Oscar Health positions in Q1 2026 and 67 closed out, a net change of -4 holders.
• The largest Oscar Health buyer in Q1 2026 was T. Rowe Price Investment Management, an estimated $34.2M added.
• The largest Oscar Health seller in Q1 2026 was Morgan Stanley, an estimated $48.7M sold.

Based on aggregated 13F filings for Q1 2026.